Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.20
Bid: 149.40
Ask: 149.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.134%)
Open: 149.00
High: 153.20
Low: 148.20
Prev. Close: 149.20
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM / Interim Management Statement

26 Apr 2012 07:00

RNS Number : 0942C
Elementis PLC
26 April 2012
 



 

26 April 2012

 

AGM / Interim Management Statement

 

Elementis plc (ELM.L, "the Company" or "the Group") today issues its Interim Management Statement for the three months ended 31 March 2012.

 

Commenting on the Company's performance Group Chief Executive, David Dutro, said: "Trading for the first three months of the year is ahead of the same period last year reflecting excellent progress in a number of key markets, which more than offset an anticipated general slowdown in Europe. The trend of robust margins, in combination with a solid order book, has continued and we expect full year earnings to be in line with market expectations."

 

In Specialty Products, sales in the first quarter were 7 per cent ahead of the same period last year as the business continued to benefit from its strategy of supplying high value products and technical service to a diversity of markets and high growth sectors.

 

·; Sales of coatings additives grew by 22 per cent in North America as the business benefited from improving customer demand and market share gains. Additives sales in Asia Pacific grew by 2 per cent, with improved margins. Sales in Europe were 8 per cent lower than the same period last year, reflecting the anticipated slowdown.

 

·; Sales to the oil and gas drilling sectors continue to show very strong growth, with sales up 42 per cent compared to the same period last year. Additives sales for both shale drilling and unconventional, high temperature, high pressure drilling continued to be the main contributors to the rapid growth and the business is investing in additional manufacturing capacity to support customer demand.

 

·; Sales in personal care were 3 per cent higher than the same period last year, reflecting further steady progress.

 

In Chromium, sales were 13 per cent higher than the same period last year. The increase in sales in the current period was partly the result of a planned plant closure in the early part of last year, in order to convert the US plant from heavy fuel oil to natural gas. Otherwise the business operated at high rates of capacity utilisation in both periods and, as such, we expect the rate of sales growth to be more modest across the remainder of the year. This key project was completed in April of last year and, together with a steady fall in US gas prices, resulted in energy costs being approximately $3 million lower in the first quarter of 2012 compared to the same period last year. The business has continued to optimise its flexible North American based operating model to generate stable earnings and cash flow. This flexibility ensured that the business has been able to replace softer European export sales with sales to more robust markets in North America. As a consequence sales to the domestic North American markets represented 65 per cent of Chromium sales, compared to 58 per cent in the same period last year.

 

The Group has an ongoing programme to invest in new products and manufacturing capacity to support growth in Specialty Products, and will continue to seek acquisitions that would enhance the geographic diversity and product offering of the business. In the meantime the Group continues to benefit from high levels of cash flow generation and a strong balance sheet, with a net cash position. The Board is in the process of reviewing the appropriate balance between cash reinvestment and shareholder returns and expects to provide an update on this at the time of the announcement of its Interim Results.

 

 

 

Enquiries:

Elementis + 44 (0) 207 408 9300

Brian Taylorson, Finance Director

  

FTI Consulting

 + 44 (0) 207 831 3113

Deborah Scott

Matthew Cole

  

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGMGZDMKLGZZZ
Date   Source Headline
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review
1st Sep 20229:00 amRNSTotal Voting Rights
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.